HomeACAD • NASDAQ
add
ACADIA Pharmaceuticals Inc
Previous close
$19.60
Day range
$18.47 - $19.69
Year range
$14.15 - $24.27
Market cap
3.07B USD
Avg Volume
1.73M
P/E ratio
13.60
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 259.60M | 12.36% |
Operating expense | 130.08M | 16.70% |
Net income | 143.74M | 213.87% |
Net profit margin | 55.37 | 179.36% |
Earnings per share | 0.86 | 207.14% |
EBITDA | 9.56M | -73.87% |
Effective tax rate | 10.77% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 755.99M | 72.26% |
Total assets | 1.19B | 58.59% |
Total liabilities | 454.96M | 43.43% |
Total equity | 732.79M | — |
Shares outstanding | 166.54M | — |
Price to book | 4.45 | — |
Return on assets | 1.61% | — |
Return on capital | 2.49% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 143.74M | 213.87% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California. Wikipedia
Founded
1993
Headquarters
Website
Employees
653
